HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New insights in the structure and biology of the high affinity receptor for IgE (Fc epsilon RI) on human epidermal Langerhans cells.

Abstract
The recent structural and functional analysis of the high affinity receptor for IgE (Fc epsilon RI) expressed on human epidermal Langerhans cells (LC) revealed new aspects of the biology of this structure. In contrast to basophils and mast cells where this receptor seems to be expressed constitutively at a constant level, the expression of Fc epsilon RI on LC varies on the donor and the inflammatory environment of the cells and lacks the classical beta-chain. This also implies functional differences most probably related to the expression level. Although the signalling pathway seems to be similar to that of basophils or mast cells, LC from individuals with atopic dermatitis are fully activated by receptor ligation while LC from normal individuals fail to exhibit calcium mobilization under the same conditions. Finally, LC from normal and atopic individuals use Fc epsilon RI to maximize antigen uptake via specific IgE and subsequent presentation to T cells. Thus, Fc epsilon RI expressed on LC differs in terms of structure and function from that expressed on effector cells of anaphylaxis.
AuthorsT Bieber, S Kraft, M Jürgens, I Strobel, J Haberstok, H Tomov, D Regele, H de la Salle, A Wollenberg, D Hanau
JournalJournal of dermatological science (J Dermatol Sci) Vol. 13 Issue 1 Pg. 71-5 (Oct 1996) ISSN: 0923-1811 [Print] Netherlands
PMID8902656 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, IgE
  • Calcium
Topics
  • Antigen Presentation
  • Basophils (immunology)
  • Calcium (metabolism)
  • Dermatitis, Atopic (immunology, metabolism)
  • Humans
  • In Vitro Techniques
  • Langerhans Cells (immunology, metabolism)
  • Mast Cells (immunology)
  • Molecular Structure
  • Receptors, IgE (chemistry, metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: